AkamisBio (@akamisbio) 's Twitter Profile
AkamisBio

@akamisbio

Akamis Bio uses its T-SIGn® platform to enter solid tumors & turn them into “drug factories” to enable the immune system’s attack on the tumor from the inside.

ID: 222289656

linkhttps://www.akamisbio.com/ calendar_today03-12-2010 00:13:13

309 Tweet

991 Followers

744 Following

AkamisBio (@akamisbio) 's Twitter Profile Photo

We have a new name, fit for a warrior. PsiOxus Therapeutics is now Akamis Bio! Today we also announced a $30M convertible note financing led by ARCH Venture Partners, Parker Institute for Cancer Immunotherapy & WestlakeVillageBioPartners that will further leverage our T-SIGn® tumor #genetherapy platform. #solidtumors